Fibroblast collagen synthesis pathway

The fibroblast collagen synthesis pathway is a complex biological process responsible for the production, modification, and secretion of collagen fibers, which constitute the primary structural component of the extracellular matrix (ECM). Fibroblasts synthesize procollagen chains that undergo critical post-translational modifications, such as hydroxylation of proline and lysine residues—a step requiring Vitamin C as a cofactor—before being secreted into the extracellular space (NCBI, 2023). Once extracellular, propeptides are cleaved, and collagen molecules self-assemble into fibrils, which are subsequently cross-linked by enzymes like lysyl oxidase to provide tensile strength to tissues (StatPearls, 2023). Dysregulation of this pathway is a central driver in various fibrotic diseases, where overactive fibroblasts (often transformed into myofibroblasts) lead to excessive collagen deposition, resulting in organ scarring and functional impairment, such as in idiopathic pulmonary fibrosis or liver cirrhosis (PubMed, 2022). Conversely, defects in collagen synthesis can lead to connective tissue disorders like Ehlers-Danlos syndrome. Pharmacological intervention typically targets signaling nodes that activate this pathway, most notably the TGF-beta/SMAD axis, or utilizes multi-kinase inhibitors like nintedanib to reduce fibroblast proliferation and ECM production (PubChem, 2024).

Other names

Collagen biosynthesisFibroblast-mediated collagen productionExtracellular matrix synthesis pathwayProcollagen processing pathway

Inhibition of TGF-beta signaling, inhibition of tyrosine kinase receptors (VEGFR, FGFR, PDGFR), modulation of prolyl 4-hydroxylase activity, and suppression of fibroblast activation and myofibroblast differentiation.